Is the worst of the trump sell off over? These stocks look like great buys!
On this week's show: Switzer's Paul Rickard, Rex's John Sharp, CoreLogic's Tim Lawless and Coolabah Capital's Ying Yi Ann Cheng.
Tune in to the latest live episode of Mad about Money with Peter Switzer and Paul Rickard.
Roger Montgomery from Montgomery Investment Management, Warren Hebard from iSelect, Michael Knox from Morgans and Paul Rickard from Switzer join the show.
Join Peter Switzer and Paul Rickard for the latest live episode of Mad about Money.
Peter Switzer speaks to Julia Lee from Burman Invest, Adam Dawes from Shaw and Partners, Michael Gable from Fairmont Equities and Paul Rickard from Switzer.
Dr Ross Walker discusses research on basal cell cancer treatment that is similar to the COVID-19 vaccine.
Prime Value Asset Management's ST Wong, Morgans' Raymond Chan, Century 21's Charles Tarbey and Coolabah Capital's Ying Yi Ann Cheng join Peter Switzer.
Peter Switzer and Paul Rickard discuss the big money stories of the day and how they will affect you.
Peter Switzer speaks to Graham Kelly, the founder, CEO and managing director of Noxopharm (NOX).
Burman Invest's Julia Lee, Tribeca's Jun Bei Liu, Switzer's Paul Rickard and Spacetalk's Mark Fortunatow join the show.
Last week Dr Ross told us what happens when diabetics have coffee and tea every day, but what are the benefits for non-diabetics?
Peter Switzer is joined by Michael Wayne from Medallion Financial Group, Kieran Davies from Coolabah Capital and James Symond from Aussie Home Loans.
Fill in the form below to subscribe to Switzer Daily and get our latest articles, videos and podcasts sent straight to your inbox